Vestal Point Capital »

Ventyx Biosciences shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Ventyx Biosciences (VTYX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Ventyx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Ventyx Biosciences held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ventyx Biosciences by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.0M 1.3M 2.31

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Ventyx Biosciences

Citadel Advisors
Deerfield Management Company
BlackRock
Farallon Capital Management
Tang Capital Management
Vanguard Group
Octagon Capital Advisors
Redmile Group
Goldman Sachs Group
Vestal Point Capital
Geode Capital Management
Opaleye Management
State Street Corporation
Parkman Healthcare Partners
Schonfeld Strategic Advisors

View all funds holding Ventyx Biosciences